Royal Bank of Canada Lowers Andlauer Healthcare Group (TSE:AND) Price Target to C$41.00

Andlauer Healthcare Group (TSE:ANDFree Report) had its price objective lowered by Royal Bank of Canada from C$43.00 to C$41.00 in a report issued on Monday morning, BayStreet.CA reports. The firm currently has a sector perform rating on the stock.

Other research analysts have also recently issued research reports about the company. TD Securities cut their price objective on Andlauer Healthcare Group from C$54.00 to C$52.00 and set a buy rating on the stock in a research report on Monday. Scotiabank raised their price objective on shares of Andlauer Healthcare Group from C$45.00 to C$47.50 and gave the stock a sector perform rating in a report on Thursday, March 7th. CIBC raised their target price on Andlauer Healthcare Group from C$50.00 to C$52.00 and gave the stock an outperform rating in a research note on Thursday, March 7th. National Bankshares increased their price target on shares of Andlauer Healthcare Group from C$46.00 to C$47.00 and gave the stock a sector perform rating in a report on Thursday, March 7th. Finally, Eight Capital cut their price target on shares of Andlauer Healthcare Group from C$62.00 to C$58.00 and set a buy rating for the company in a report on Thursday, March 7th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of Moderate Buy and an average price target of C$49.43.

Check Out Our Latest Research Report on AND

Andlauer Healthcare Group Stock Performance

TSE AND opened at C$40.51 on Monday. The company has a current ratio of 2.52, a quick ratio of 1.66 and a debt-to-equity ratio of 27.24. The company has a fifty day simple moving average of C$42.10 and a 200 day simple moving average of C$40.51. Andlauer Healthcare Group has a 12-month low of C$36.76 and a 12-month high of C$48.80. The company has a market cap of C$789.13 million, a P/E ratio of 26.14 and a beta of 0.69.

Andlauer Healthcare Group (TSE:ANDGet Free Report) last announced its quarterly earnings results on Tuesday, March 5th. The company reported C$0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.49 by C($0.05). Andlauer Healthcare Group had a return on equity of 14.53% and a net margin of 10.21%. The company had revenue of C$169.07 million for the quarter, compared to the consensus estimate of C$165.00 million. Sell-side analysts predict that Andlauer Healthcare Group will post 1.8439434 earnings per share for the current fiscal year.

Andlauer Healthcare Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Thursday, March 28th were given a dividend of $0.10 per share. This is a positive change from Andlauer Healthcare Group’s previous quarterly dividend of $0.09. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.40 dividend on an annualized basis and a yield of 0.99%. Andlauer Healthcare Group’s dividend payout ratio is presently 23.23%.

Andlauer Healthcare Group Company Profile

(Get Free Report)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Further Reading

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.